Evidence map›Paper›PMID 41053781›Full record

ArticleBMC medical informatics and decision making2025

AI-driven prognostics in pediatric bone marrow transplantation: a CAD approach with Bayesian and PSO optimization.

Mahmoud Badawy, Yousry AbdulAzeem, Hanaa ZainEldin, Hossam Magdy Balaha, Amna Bamaqa, Rasha F El-Agamy, Hanaa A Sayed, Mostafa A Elhosseini

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mahmoud BadawyDepartment of Computer Science and Information, Applied College, Taibah University, Medinah, 42353, Saudi Arabia. engbadawy@mans.edu.eg.
Yousry AbdulAzeem *School of Computational Sciences and Artificial Intelligence, Zewail City of Science, Technology and Innovation, Giza, 12578, Egypt.
Hanaa ZainEldin *Computers and Control Systems Engineering Department, Faculty of Engineering, Mansoura University, Mansoura, 35516, Egypt.
Hossam Magdy Balaha *Computers and Control Systems Engineering Department, Faculty of Engineering, Mansoura University, Mansoura, 35516, Egypt.
Amna Bamaqa *Department of Computer Science and Information, Applied College, Taibah University, Medinah, 42353, Saudi Arabia.
Rasha F El-Agamy *Department of Information Systems, College of Computer Science and Engineering, Taibah University, Yanbu, 46421, Saudi Arabia.
Hanaa A Sayed *Department of Information Systems, College of Computer Science and Engineering, Taibah University, Yanbu, 46421, Saudi Arabia.
Mostafa A Elhosseini *Computers and Control Systems Engineering Department, Faculty of Engineering, Mansoura University, Mansoura, 35516, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow transplantation (BMT) is a critical treatment for various hematological diseases in children, offering a potential cure and significantly improving patient outcomes. However, the complexity of matching donors and recipients and predicting post-transplant complications presents significant challenges. In this context, machine learning (ML) and artificial intelligence (AI) serve essential functions in enhancing the analytical processes associated with BMT. This study introduces a novel Computer-Aided Diagnosis (CAD) framework that analyzes critical factors such as genetic compatibility and human leukocyte antigen types for optimizing donor-recipient matches and increasing the success rates of allogeneic BMTs. The CAD framework employs Particle Swarm Optimization for efficient feature selection, seeking to determine the most significant features influencing classification accuracy. This is complemented by deploying diverse machine-learning models to guarantee strong and adaptable analytical capabilities. The Adaptive Tree of Parzen Estimators (TPE), a Bayesian optimization technique, is a key component of the proposed methodology. TPE is instrumental in navigating the complex hyperparameter space to optimize model performance, enhancing the overall effectiveness of the ML algorithms. Besides, the study investigates the impact of various scaling techniques on model performance, including L1 normalization and L2 normalization, ensuring that data preprocessing is optimized for the best possible outcomes. The Local Interpretable Model-Agnostic Explanations (LIME) framework is utilized to enhance model transparency and interpretability, bridging the gap between complex AI algorithms and clinical usability. This study uses a comprehensive dataset titled "Bone Marrow Transplant: Children, which is the analysis's foundation. The findings, validated by ANOVA and T-tests, reveal significant associations between several factors and survival status, highlighting the importance of Donorage, extcGvHD, PLTrecovery, and survival_time, among others. The optimal CAD framework employs a majority voting ensemble of seven finely-tuned machine learning algorithms, achieving remarkable performance metrics. The proposed CAD framework not only achieves high accuracy (98.07%), Balanced Accuracy (98.08%), precision (98.45%), recall (98.02%), specificity (98.14%), F1 score (98.23%), and Intersection over Union (96.53%) but also offers interpretable insights into the classification procedure, contributing significantly as a comprehensive tool for clinicians in the domain of childhood BMT.

Indexed as

Artificial IntelligenceBone Marrow TransplantationDiagnosis, Computer-AssistedMachine LearningAdolescentBayes TheoremChildChild, PreschoolHumansPrognosisBayesian optimizationBone Marrow TransplantsComputer-Aided Diagnosis (CAD)Local Interpretable Model-Agnostic Explanations (LIME)Particle Swarm Optimization (PSO)

Identifiers

PMID41053781
PMCPMC12502543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.